Vitamin D and 1,25(OH)2D regulation of T cells.
Cantorna MT, Snyder L, Lin YD, Yang L. · 2015
Read Vitamin D and 1,25(OH)2D regulation of T cells. by Cantorna MT, Snyder L, Lin YD, Yang L. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4425186.txt.
Introduction
Margherita Cantorna, Lindsay Snyder, Yang-Ding Lin, and Linlin Yang reviewed vitamin D and T cells in Nutrients in 2015 and added new data of their own. Vitamin D, made in skin or taken in food, shapes immune cells both directly and through other cells. The active form is written in the article as 1,25(OH)2D.
In mice and humans, that form slows T cell growth. It lowers two inflammatory signals, IL-17 and IFN-gamma. It also raises calmer signals such as IL-4 and IL-10 and favors regulatory T cells. Effects appear late, after cells have been active for two to three days and have built the vitamin D receptor. The pattern, the authors argue, fits diseases such as bowel inflammation and multiple sclerosis.
Catalog record
| CREATOR | Cantorna MT, Snyder L, Lin YD, Yang L. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Vitamin D and 1,25(OH)2D Regulation of T cells By Margherita T. Cantorna, Lindsay Snyder, Yang-Ding Lin, Linlin Yang Published in: Nutrients DOI: 10.3390/nu7043011 ABSTRACT Vitamin D is a direct and indirect regulator of T cells. The mechanisms by which vitamin D directly regulates T cells are reviewed and new primary data on the effects of 1,25 dihydroxyvitamin D (1,25(OH)2D) on human invariant natural killer (iNK)T cells is presented. The in vivo effects of vitamin D on murine T cells include inhibition of T cell proliferation, inhibition of IFN-γ, IL-17 and induction of IL-4. Experiments in mice demonstrate that the effectiveness of 1,25(OH)2D requires NKT cells, IL-10, the IL-10R and IL-4. Comparisons of mouse and human T cells show that 1,25(OH)2D inhibits IL-17 and IFN-γ, and induces T regulatory cells and IL-4. IL-4 was induced by 1,25(OH)2D in mouse and human iNKT cells. Activation for 72h was required for optimal expression of the vitamin D receptor (VDR) in human and mouse T and iNKT cells. In addition, T cells are potential autocrine sources of 1,25(OH)2D but again only 48–72h after activation. Together the data support the late effects of vitamin D on diseases like inflammatory bowel disease and multiple sclerosis where reducing IL-17 and IFN-γ, while inducing IL-4 and IL-10, would be beneficial. 1. INTRODUCTION Vitamin D is a fat soluble vitamin that is either consumed in the diet or produced in the skin following sunlight exposure of the skin. Vitamin D is inactive and is hydroxylated twice, once in the liver and once in the kidney to make the active form of the vitamin, 1,25 dihydroxyvitamin D (1,25(OH)2D) [1,2]. Production of 1,25(OH)2D in the kidney is tightly regulated by serum calcium, parathyroid hormone and 1,25(OH)2D levels [3]. Vitamin D as 1,25(OH)2D functions by binding to a nuclear vitamin D receptor (VDR) and retinoid X receptor to regulate gene transcription [4]. The classic roles of vitamin D are in the regulation of calcium uptake and homeostasis, bone metabolism, and cell growth and division. The VDR has been identified in many other tissues including the immune system and it is now accepted that 1,25(OH)2D and vitamin D are important immune system regulators [5]. All cells of the immune system have been shown to express the VDR including T cells [6]. 2. T CELLS Several different types of T cells exist to provide defense from a variety of different insults to the body. CD4+ T cells provide help for B cell antibody production and to other cell types to engulf and kill pathogens. T helper (h) cell responses are heterogeneous although it has been shown that specific cytokine patterns are critical for control of susceptibility to infection. Th1 cells are important for the control of intracellular infections with Mycobacterium tuberculosis, Listeria monocytogenes, and a number of viruses [7,8,9]. Th2 cells that produce IL-4, IL-5, and IL-13 are required for host defense against parasitic helminthes [10]. Th17 cells produce IL-17, IL-22, and granulocyte macrophage-colony stimulating factor (GM-CSF) [11] and are essential for resistance to extracellular pathogens [12]. Additional T cells include the innate natural killer (NK)T cells. NKT cells recognize lipid antigens instead of protein antigens and produce large amounts of cytokines early during infection [13]. CD8+ T cells are cytotoxic T cells and are important for killing virally and bacterially infected cells. Each of these T cells are critical for immune protection from infection. Dysregulation of T cell responses can cause pathology. Immune mediated diseases occur as a result of chronically activated T cells. T regulatory (reg) cells produce IL-10 and serve to inhibit effector T cell responses in an antigen specific and non-specific manner [14]. Deficiency of T reg cells results in multi-organ immune mediated disease [14]. Th1 and/or Th17 cells transfer experimental models of immune mediated diseases such as inflammatory bowel disease and multiple sclerosis. Experimental asthma and allergy models occur in animals that have Th2 cells, and in some cases NKT cells that overproduce IL-13 and/or IL-17 [15]. Control of the T cell response is therefore required for robust elimination of infection and the resolution of inflammation to prevent pathology due to chronic T cell activation. 3. VITAMIN D AND T CELLS The effects of vitamin D and 1,25(OH)2D as inhibitors of T cells have been well described. There are direct and indirect effects of 1,25(OH)2D on T cells but this review will focus on the direct effects. Since 1983 it has been described that 1,25(OH)2D inhibited T cell proliferation and the secretion of select cytokines after mitogen stimulation [16,17]. Moreover, 1,25(OH)2D directly inhibited IL-2 and IFN-γ transcription [17,18]. More recently 1,25(OH)2D has also been shown to inhibit IL-17 secretion by Th17 cells [19,20]. The effects of 1,25(OH)2D on Th2 cells is more controversial with evidence that 1,25(OH)2D inhibits IL-4 transcriptionally as well as evidence that 1,25(OH)2D upregulates IL-4 in mouse and human T cells [20,21,22,23]. In vitro, 1,25(OH)2D3 treatments induced IL-10 and T regulatory cell development [24]. In addition, 1,25(OH)2D upregulated the gut homing receptor CCR9 and inhibited CXCR3 on T cells potentially changing the homing properties of the Th cells [25]. Vitamin D and 1,25(OH)2D inhibited Th1 and Th17 responses, induced T reg responses, and controlled proliferation and Th cell localization. CD8+ T cells and iNKT cells are also vitamin D targets. In vitro, 1,25(OH)2D treatment inhibited CD8 T cell proliferation and VDR knockout (KO) CD8+ T cells proliferated without antigen stimulation due in part to over-production of IL-2 [26,27]. VDR KO CD8 T cells had altered homing patterns, a reduction in granzyme B production and more rapid contraction in an infection model [28]. Other defects in VDR KO CD8+ T cells included the ability, when transferred to leucopenic hosts, to develop into IL-17 and IFN-γ secreting cells that produced colitis symptoms [26]. In the gastrointestinal tract, CD8αα/TCRαβ T cells important in maintaining homeostasis, required vitamin D to maintain their homeostatic proliferation [29]. Development and function of iNKT cells depends on expression of the VDR and vitamin D [30,31]. In vitro, 1,25(OH)2D inhibited iNKT cell derived IL-17 and induced IL-4 and IL-5 [32]. The requirement for the VDR in the development of iNKT cells was traced to regulation of the survival of maturing iNKT cells in the thymus [31]. Vitamin D controls CD8 proliferation, IL-2 production and the potential to develop into effector T cells that produce IFN-γ, IL-17 and granzyme B. Vitamin D also controls iNKT cell expansion during development. Lastly vitamin D changes early cytokine production by iNKT cells that could shape later T cell responses. The effectiveness of vitamin D and 1,25(OH)2D treatments on animal models of T cell mediated diseases has been informative. Th1 and Th17 cells cause experimental autoimmune encephalomyelitis (EAE, murine model of multiple sclerosis), inflammatory bowel disease and type-1 diabetes. In vivo, 1,25(OH)2D treatments suppressed the development and progression of these Th1/Th17 mediated diseases [33,34,35]. In addition, vitamin D and VDR deficiency exacerbated experimental type-1 diabetes and inflammatory bowel disease in mice [33,35,36]. In EAE the effectiveness of 1,25(OH)2D has been shown to require iNKT cells, IL-4, IL-10, and L-10R [32,37,38]. In addition, the 1,25(OH)2D-mediated inhibition of IL-17 and IFN-γ with the induction of IL-10 and T reg cells have been suggested as mechanisms to explain suppression of experimental EAE, IBD